Repligen Co. (NASDAQ:RGEN) Given Consensus Rating of “Moderate Buy” by Brokerages
Shares of Repligen Co. (NASDAQ:RGEN – Get Free Report) have received an average recommendation of “Moderate Buy” from the fourteen research firms that are covering the company, MarketBeat reports. Six investment analysts have rated the stock with a hold recommendation and eight have issued a buy recommendation on the company. The average 12-month target price […]
Shares of Repligen Co. (NASDAQ:RGEN – Get Free Report) have received an average recommendation of “Moderate Buy” from the fourteen research firms that are covering the company, MarketBeat reports. Six investment analysts have rated the stock with a hold recommendation and eight have issued a buy recommendation on the company. The average 12-month target price […]